Table 1.
Baseline clinical characteristics of the overall cohort of patients and of patients grouped according to stroke etiology.
| Overall Cohort of Patients (N = 80) | LAA (N = 40) | CE (N = 40) | Statistical Analysis | |
|---|---|---|---|---|
| Admission NIHSS a | 14 [9–19] | 15 [9–19] | 14 [9–19] | H1 = 0.53, p = 0.818 |
| rtPA b administration | ||||
| rtPA yes | 39 | 20 | 19 | X1 = 0.050, p = 0.823 |
| rtPA no | 41 | 20 | 21 | |
| Occluded vessel(s) c | ||||
| MCA, M1 | 41 (51.2%) | 13 (32.5%) | 28 (70.0%) | H1 = 16.460, p < 0.0001 * |
| MCA, M2 | 5 (6.3%) | 2 (5.0%) | 3 (7.5%) | |
| MCA, M3 | 1 (1.3%) | 0 (0.0%) | 1 (2.5%) | |
| MCA, not specified | 2 (2.5) | 1 (2.5%) | 1 (2.5%) | |
| MCA (multiple branches/segments) | 1 (1.3%) | 0 (0.0%) | 1 (2.5%) | |
| ICA and ICA terminus | 6 (7.5%) | 4 (10.0%) | 2 (5.0%) | |
| ACA | 1 (1.3%) | 0 (0.0%) | 1 (2.5%) | |
| VB | 6 (7.5%) | 4 (10.0%) | 2 (5.0%) | |
| Tandem occlusion | 15 (18.8%) | 14 (35.0%) | 1 (2.5%) | |
| 3 Or more occluded vessels | 2 (2.5%) | 2 (5.0%) | 0 (0.0%) | |
| Final mTICI d score | ||||
| mTICI 0 | 2 (2.5%) | 1 (2.5%) | 1 (2.5%) | H1 = 0.397, p = 0.529 |
| mTICI 1 | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | |
| mTICI 2a | 1 (1.3%) | 1 (2.5%) | 0 (0.0%) | |
| mTICI 2b | 12 (15.0%) | 7 (17.5%) | 5 (12.5%) | |
| mTICI 2c | 17 (21.3%) | 8 (20.0%) | 9 (22.5%) | |
| mTICI 3 | 48 (60.0%) | 23 (57.5%) | 25 (62.5%) |
a NIHSS: National Institutes of Health Stroke Scale, N = 77, 37 LAA and 40 CE patients. b rtPA: recombinant tissue plasminogen activator c MCA: middle cerebral artery; ICA: internal carotid artery; ACA: anterior cerebral artery; VB: vertebro-basilar. d mTICI: modified treatment in Cerebral Ischemia. Data shown as N (%) of cases or median [IQ1, IQ3]. * indicates a statistically significant difference.